Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight

Abroad (travel likely)RecruitingPHASE2

Conditions

Obesity

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
Contact: Study coordinator (Zhen J Peng, Phd) · Zhen-Peng@beijing-biotech.com · +8613076790039

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Obesity · Overweight · Diabetes Mellitus, Type 2

Abroad (travel likely)RecruitingPHASE2

Gilbert, United States · Phoenix, United States

Glucagon-Like Peptide-1 Receptor Agonist in ADPKD

Autosomal Dominant Polycystic Kidney · Obesity

Abroad (travel likely)RecruitingPHASE2

Aurora, United States

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Atherosclerotic Cardiovascular Disease · Overweight · Obesity

Abroad (travel likely)RecruitingPHASE3

Daphne, United States · Fairhope, United States

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Obesity · Overweight · Obstructive Sleep Apnoea

Abroad (travel likely)RecruitingPHASE3

Gilbert, United States · Bradenton, United States